Centre Hospitalier Universitaire d’Orléans
- Address
- lock Available on a paid plan
Viral Disease Research at Centre Hospitalier Universitaire d’Orléans
This site is conducting clinical research in virus diseases, with a focus on HIV-1 infection. The studies are designed to explore better ways to control the virus and support long-term treatment success in adults living with HIV.
- Evaluating the effectiveness of new antiretroviral therapy approaches for people starting HIV treatment
- Assessing whether treatment can maintain viral suppression over time with simpler care options
- Comparing patient-centered treatment strategies for improved convenience and adherence
The research in this area aims to improve both treatment effectiveness and the overall experience of care for HIV patients.
Digestive System Disease Research
Clinical trials in digestive system diseases at the Hépato-Gastroentérologie department are centered on primary biliary cholangitis in patients who do not respond well enough to standard therapy. These studies are looking at whether additional treatment options can improve disease control.
- Testing adjunctive treatments for patients with a non-optimal response to ursodeoxycholic acid
- Studying ways to improve biochemical response in primary biliary cholangitis
- Comparing new supportive strategies against placebo to assess treatment benefit
The goal is to refine care for chronic liver-related conditions and identify options that may offer better disease management for people with PBC.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 22 therapeutic areas and 15 of 266 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 234 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 40 by active trials.
lock +39 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +27 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier Universitaire d’Orléans
lock Showing 1 of 147 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicentre, double-blind, randomized controlled trial of inhaled amikacin versus placebo in critically ill patients with ventilator-associated tracheobronchitis (AMIVAT) | Centre Hospitalier Regional Universitaire De Tours | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 266 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Sodium Chloride | 11 | Unknown | 2021-07-18 | 2026-07-03 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.